E
Mind Medicine (MindMed) Inc. MMED
Recommendation
Prev Close
$14.90
Volume
--
Avg Vol (90D)
0
Market Cap
$474.82M
Dividend & Yield
--
52-Week Range
$11.60 - $15.07
P/E (TTM)
--
EPS (TTM)
-$2.08
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
There are no news to display.
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
-$103.89M
EBIT (TTM)
-$103.92M
Net Income (TTM)
-$108.68M
Balance Sheet
Total Assets (Q)
$302.15M
Total Debt (Q)
$21.85M
Total Liabilities (Q)
$60.70M
Book Value Per Share (Q)
$3.22
Cash Flow
Cash from Operations (TTM)
-$79.13M
Cash from Investing (TTM)
--
Cash from Financing (TTM)
$253.20M
Net Change in Cash (TTM)
$174.04M
Filings
Filing Date
Thursday, March 6, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Loading...
Beta
0.53
7-Day Total Return
--
30-Day Total Return
--
60-Day Total Return
--
90-Day Total Return
--
Year to Date Total Return
--
1-Year Total Return
--
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
Apr 29, 2025 - $11.60
52-week High
Apr 29, 2025 - $15.07
Valuation
Market Cap
$474.82M - Small Cap
Enterprise Value
$222.93M
Price/Sales (TTM)
--
Price/Book (Q)
4.63
Dividends and Shares
Shares Outstanding
83.93M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.mindmed.co
Phone Number
212 220 6633
Address
One World Trade Center
New York, NY 10007
Country
United States
Year Founded
--
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company’s lead product candidates include MM120, which is in... more